Fred Hausheer, MD, PhD, FACP
Senior Vice President and Global Chief Medical Officer at WuXi Apptec, China
Dr. Hausheer currently serves as Senior Vice President and Global Chief Medical Officer at WuXi Apptec, a global pharmaceutical, biopharmaceutical, and medical device company based in Shanghai, China.
Dr. Hausheer possesses rich experience in global preclinical and Phase I-III oncology drug development, translational science and medicine in commercial and academic settings, formerly holding positions as CEO and CMO of several Biopharma companies, as well as founding BioNumerik Pharmaceuticals, which focused on the discovery, development and commercialization of novel drugs for the treatment of cancer and cancer supportive care. He has also served as a business advisory board member to JP Morgan Chase, the Whittaker Institute at Johns Hopkins, and the National Cancer Institute.
Dr. Hausheer was educated and trained at the University of Missouri in Internal Medicine and conducted his fellowship in medical oncology at the prestigious Johns Hopkins University. Certified in Internal Medicine and Medical Oncology from the esteemed American Board of Internal Medicine, he is an active member of the American Society of Clinical Oncology and speaks around the globe at universities, conferences, and meetings as well.